Alembic Pharmaceuticals Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its ...

This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat various cancers and autoimmune conditions such as rheumatoid arthritis and ...

The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has recommended new measures to reduce the risk of dosing errors with medicines containing methotrexate.

Alembic Pharmaceuticals' shares rose after receiving USFDA approval for its generic cancer treatment drug, Methotrexate ...

Methotrexate Injection is used in the treatment of multiple conditions, including various cancers such as acute lymphoblastic ...

Alembic Pharmaceuticals receives USFDA approval for a generic methotrexate injection used in treating cancer and arthritis.

Alembic Pharmaceuticals advanced 2.35% to Rs 752.20 after the company announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug ...

Adalimumab monotherapy and combination with methotrexate showed similar drug survival and PASI75 response rates in plaque psoriasis patients. Methotrexate reduced antidrug antibody levels but did not ...

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Methotrexate ...

The US Food and Drug Administration (FDA) has approved concomitant use of the biologic pegloticase (Krystexxa) and methotrexate to lower serum uric acid levels (sUA) in patients with chronic gout.